Hematologic Tumor Cell Resistance to the BCL-2 Inhibitor Venetoclax: A Product of Its Microenvironment?

Overview of attention for article published in Frontiers in oncology, October 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (60th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter: 1 X user

patent: 1 patent

Readers on

mendeley: 70 Mendeley

Summary X Patents

So far, Altmetric has seen 1 patent that references this research output.

COMBINATIONAL MEDICATION

Application EP-3932429-A4

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.